review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1474-4422(16)30358-1 |
P698 | PubMed publication ID | 27964824 |
P50 | author | Gabriele Mora | Q76745763 |
Adriano Chiò | Q30003371 | ||
P2093 | author name string | Giuseppe Lauria | |
P2860 | cites work | Amyotrophic lateral sclerosis causes small fiber pathology | Q59698113 |
Small-fibre neuropathy related to bulbar and spinal-onset in patients with ALS | Q60705178 | ||
Chronic pain syndrome in amyotrophic lateral sclerosis | Q71758722 | ||
Shoulder pain in amyotrophic lateral sclerosis | Q83504878 | ||
Diagnosis of neuropathic pain: challenges and possibilities | Q86352960 | ||
Amyotrophic Lateral Sclerosis Incidence and Previous Prescriptions of Drugs for the Nervous System | Q88204204 | ||
Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease | Q24200285 | ||
Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease | Q24202239 | ||
Quinine for muscle cramps | Q24235626 | ||
Acupuncture for shoulder pain | Q24243942 | ||
Physiotherapy interventions for shoulder pain | Q24248777 | ||
Depressive symptoms in neurodegenerative diseases | Q26798063 | ||
Characteristics of pain in amyotrophic lateral sclerosis | Q30316800 | ||
Rehabilitation in amyotrophic lateral sclerosis: why it matters | Q30407969 | ||
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression | Q30866592 | ||
Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes | Q30873214 | ||
The cerebral signature for pain perception and its modulation | Q31120834 | ||
Pain in motor neuron disease | Q33621366 | ||
Chronic pain in persons with neuromuscular disease | Q33987789 | ||
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision | Q34110857 | ||
Dyspnea-pain counterirritation induced by inspiratory threshold loading: a laser-evoked potentials study | Q34135468 | ||
Central sensitization: Implications for the diagnosis and treatment of pain | Q34144741 | ||
Determinants of accepting non-invasive ventilation treatment in motor neurone disease: a quantitative analysis at point of need | Q34182042 | ||
Cannabinoid-opioid interaction in chronic pain | Q34229641 | ||
Evidence for a central component of post-injury pain hypersensitivity | Q34265604 | ||
Clinical practice. Chronic pruritus | Q34341078 | ||
Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010. | Q34375695 | ||
Muscle cramps | Q34419913 | ||
Neuropathic pain: redefinition and a grading system for clinical and research purposes | Q34713765 | ||
Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the Am | Q35007618 | ||
Electrophysiological and spinal imaging evidences for sensory dysfunction in amyotrophic lateral sclerosis | Q35126997 | ||
Depression in amyotrophic lateral sclerosis | Q35163766 | ||
Motor neurone disease: a hospice perspective | Q35819817 | ||
The epidemiology of pain in depression | Q35892386 | ||
Pain and temperature processing in dementia: a clinical and neuroanatomical analysis | Q36206029 | ||
Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study | Q36227026 | ||
Natural history of muscle cramps in amyotrophic lateral sclerosis. | Q36643076 | ||
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression | Q36813236 | ||
Skin biopsy as a diagnostic tool in peripheral neuropathy. | Q36959849 | ||
Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. | Q37028728 | ||
Patient-reported problematic symptoms in an ALS treatment trial. | Q37164599 | ||
Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis | Q37184758 | ||
The use of integrative therapies in patients with amyotrophic lateral sclerosis in shanghai, china | Q37398227 | ||
Drug-induced pruritus: a review | Q37499989 | ||
Interdisciplinary palliative care, including massage, in treatment of amyotrophic lateral sclerosis | Q37599038 | ||
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force | Q37931374 | ||
Combination therapy for neuropathic pain: a review of current evidence | Q37963569 | ||
A review of experimental research on herbal compounds in amyotrophic lateral sclerosis | Q38092021 | ||
Neuropathic pruritus. | Q38218849 | ||
A Qualitative Study of Multidisciplinary ALS Clinic Use in the United States | Q38617893 | ||
Physical Activity and Early Rehabilitation in Hospitalized Elderly Medical Patients: Systematic Review of Randomized Clinical Trials. | Q38921269 | ||
The role of mental health and self-efficacy in the pain experience of patients with amyotrophic lateral sclerosis. | Q39176665 | ||
Attitude of outpatients with neuromuscular diseases in Japan to pain and use of analgesics | Q39329403 | ||
Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief | Q39329951 | ||
Survey of cannabis use in patients with amyotrophic lateral sclerosis | Q39382412 | ||
Pain in amyotrophic lateral sclerosis: a population-based controlled study. | Q39700757 | ||
ALS mouse model SOD1G93A displays early pathology of sensory small fibers associated to accumulation of a neurotoxic splice variant of peripherin | Q39974165 | ||
The Role of APOE in the Occurrence of Frontotemporal Dementia in Amyotrophic Lateral Sclerosis | Q39977770 | ||
Pain in amyotrophic lateral sclerosis: Patient and physician perspectives and practices. | Q40380353 | ||
Predictors and correlates of interest in assisted suicide in the final month of life among ALS patients in Oregon and Washington | Q40618574 | ||
Depression in ALS in a large self-reporting cohort | Q40903244 | ||
18F-FDG-PET correlates of cognitive impairment in ALS. | Q41108738 | ||
The quality of care and symptom control--the effects on the terminal phase of ALS/MND. | Q41194833 | ||
Is there pain with neuropathic characteristics in patients with amyotrophic lateral sclerosis? A cross-sectional study. | Q41487079 | ||
Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder? | Q42765711 | ||
Pain in amyotrophic lateral sclerosis: a neglected aspect of disease | Q42797616 | ||
Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial. | Q43055391 | ||
Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials. | Q43075467 | ||
Depression in chronic pain patients: prevalence and measurement | Q43456944 | ||
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis | Q43569621 | ||
Amyotrophic lateral sclerosis care in Italy: a nationwide study in neurological centers. | Q43777133 | ||
The last months of life of people with amyotrophic lateral sclerosis in mechanical invasive ventilation: a qualitative study | Q44033907 | ||
The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study | Q44591084 | ||
Prevalence and characteristics of pain in early and late stages of ALS. | Q44705987 | ||
Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease | Q46343764 | ||
Osteopathic Manual Treatment for Amyotrophic Lateral Sclerosis: A Feasibility Pilot Study. | Q47168226 | ||
Disparities in perceptions of distress and burden in ALS patients and family caregivers. | Q47337859 | ||
Correlates of suffering in amyotrophic lateral sclerosis | Q47348801 | ||
Ventilator dependence and expressions of need: a study of patients with amyotrophic lateral sclerosis in Japan | Q47607921 | ||
Iyengar yoga therapy as an intervention for cramp management in individuals with amyotrophic lateral sclerosis: three case reports | Q48127165 | ||
Dyspnea as a noxious sensation: inspiratory threshold loading may trigger diffuse noxious inhibitory controls in humans | Q48461885 | ||
Sporadic motor neuron disease with severe sensory neuronopathy | Q48483957 | ||
Pain in Amyotrophic Lateral Sclerosis: a psychological perspective | Q48515636 | ||
Absence of SOD1 gene abnormalities in familial amyotrophic lateral sclerosis with posterior column involvement without Lewy-body-like hyaline inclusions | Q48879026 | ||
Structural brain correlates of cognitive and behavioral impairment in MND. | Q48934859 | ||
Involvement of distal sensory nerves in amyotrophic lateral sclerosis. | Q50661254 | ||
Requests for euthanasia: origin of suffering in ALS, heart failure, and cancer patients. | Q50707459 | ||
Secondary hyperalgesia to punctate mechanical stimuli. Central sensitization to A-fibre nociceptor input. | Q51430960 | ||
Neurologic disease at the end of life: caregiver descriptions of Parkinson disease and amyotrophic lateral sclerosis. | Q51891176 | ||
Clinical indicators of 'nociceptive', 'peripheral neuropathic' and 'central' mechanisms of musculoskeletal pain. A Delphi survey of expert clinicians. | Q53059559 | ||
What are we doing to waiting list controls? | Q53415465 | ||
Subjective experience and coping in ALS | Q54738846 | ||
Amyotrophic lateral sclerosis | Q55877676 | ||
Cramps, muscle pain, and fasciculations: not always benign? | Q56929777 | ||
Small-fiber neuropathy in patients with ALS | Q57232614 | ||
Reassessing received wisdom in ALS - pain is common when studied systematically | Q57357887 | ||
Amyotrophic lateral sclerosis: clinical analysis of 78 cases from Fortaleza (Northeastern Brazil) | Q57450699 | ||
7-T MRI of the spinal cord can detect lateral corticospinal tract abnormality in amyotrophic lateral sclerosis | Q57592495 | ||
Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey | Q58188222 | ||
The evaluation of pain in amyotrophic lateral sclerosis: A case controlled observational study | Q58293600 | ||
The value of muscle exercise in patients with amyotrophic lateral sclerosis | Q59416877 | ||
P433 | issue | 2 | |
P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
P304 | page(s) | 144-157 | |
P577 | publication date | 2016-12-07 | |
P1433 | published in | Lancet Neurology | Q15755067 |
P1476 | title | Pain in amyotrophic lateral sclerosis | |
P478 | volume | 16 |
Q56531747 | Amyotrophic lateral sclerosis |
Q47790158 | Beyond weakness: Characterization of pain, sensory profile and conditioned pain modulation in patients with motor neuron disease: A controlled study. |
Q90702960 | Brain Abscess Presenting as Prolonged Headache in a Patient with Amyotrophic Lateral Sclerosis under Mechanical Ventilation |
Q48153881 | Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy |
Q98281049 | No association between proton pump inhibitor use and ALS risk: a nationwide nested case-control study |
Q92489514 | Physical therapy for individuals with amyotrophic lateral sclerosis: current insights |
Q93185685 | Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives |
Q92697340 | Tapentadol for neuropathic pain: a review of clinical studies |